CAS 120511-73-1: Anastrozole
Description:Anastrozole is a non-steroidal aromatase inhibitor primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Its mechanism of action involves the inhibition of the aromatase enzyme, which is responsible for converting androgens into estrogens, thereby reducing estrogen levels in the body. This reduction is crucial as many breast cancers are fueled by estrogen. Anastrozole is typically administered orally and is known for its favorable pharmacokinetic profile, including good absorption and a relatively long half-life, allowing for once-daily dosing. Common side effects may include hot flashes, joint pain, and fatigue, among others. The substance is classified as a prescription medication and is often part of adjuvant therapy following surgery or radiation. Anastrozole is recognized for its effectiveness in improving disease-free survival rates in breast cancer patients, making it a significant option in oncological pharmacotherapy. Its chemical structure features a triazole ring, contributing to its specificity and efficacy as an aromatase inhibitor.
Formula:C17H19N5
InChI:InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3
InChI key:InChIKey=YBBLVLTVTVSKRW-UHFFFAOYSA-N
SMILES:N#CC(C1=CC(=CC(=C1)C(C#N)(C)C)CN2N=CN=C2)(C)C
- Synonyms:
- 1,3-Benzenediacetonitrile, α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-Benzenediacetonitrile,Alpha,Alpha,Alpha',Alpha'-Tetramethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-
- 1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
- 1-[3,5-Di-(1-Methyl-1-Cyano)-Ethyl]-Benzyl-1,2,4-Triazole
- 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
- 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)
- 2-[3-(1-Cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile
- 2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile
- 2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
- Anastrazole
- See more synonyms
- Anastrol
- Anastrozol
- Anatrozole
- Arimidex
- Ici-D-1033
- Tetramethyl-5-(1H-1,2,4-Triazol-1Ylmethyl) 1,3-Benzenediacetionitrile
- Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile
- ZD-1033, ICI-D-1033, Arimidex
- Zd
- Zd-1033
- α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
- Anastrozole
- 1,3-Benzenediacetonitrile, α1,α1,α3,α3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)-
- zd
- α1,α1,α3,α3-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile

Anastrozole
Ref: 3B-A2370
100mg | 30.00 € |

Anastrozole
Ref: 47-1213
100mg | 242.00 € |

Ref: 41-Y0001522
100mg | 115.00 € |

Anastrozole
Ref: 45-1034807
200mg | 736.00 € |

Anastrozole
Ref: TM-T0393
10mg | 49.00 € | ||
25mg | 66.00 € | ||
50mg | 85.00 € | ||
1mL*10mM (DMSO) | 52.00 € |

Anastrozole
Ref: 4Z-A-241
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

Anastrozole
Controlled ProductRef: 04-C10248750
100mg | 130.00 € |

Anastrozole, 98%
Ref: AC-46097
1g | 506.00 € | ||
250mg | To inquire |

Anastrozole
Controlled ProductRef: 86-MM1250.00
250mg | 301.00 € |

Anastrozole
Ref: 7W-GP2172
10mg | 93.00 € | ||
25mg | 192.00 € |

Ref: 2K-1007500021
300mg | To inquire |

Anastrozole
Controlled ProductRef: TR-A637425
10mg | 106.00 € | ||
50mg | 191.00 € | ||
100mg | 264.00 € |

Anastrozole - Bio-X ™
Controlled ProductRef: 3D-BT164176
10mg | 145.00 € |

Anastrozole
Controlled ProductRef: 3D-FT10600
1g | 403.00 € | ||
5g | 854.00 € | ||
10g | 1,179.00 € | ||
25g | 1,875.00 € | ||
500mg | 243.00 € |